(Q54780755)

3 June 2018

review article

1 reference

title

[Oxidative stress: a review on metabolic signaling in type 1 diabetes]. (English)

1 reference

3 June 2018

main subject

type-1 diabetes

0 references

author name string

Janice Sepúlveda Reis

1

1 reference

3 June 2018

Clara Araújo Veloso

2

1 reference

3 June 2018

Rafael Teixeira Mattos

3

1 reference

3 June 2018

Saulo Purish

4

1 reference

3 June 2018

José Augusto Nogueira-Machado

5

1 reference

3 June 2018

language of work or name

Portuguese

0 references

publication date

1 October 2008

1 reference

3 June 2018

Arquivos Brasileiros de Endocrinologia e Metabologia

published in

1 reference

3 June 2018

volume

52

1 reference

3 June 2018

issue

7

1 reference

3 June 2018

page(s)

1096-1105

1 reference

3 June 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Reactive oxygen species in the vasculature: molecular and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Nitric oxide and oxygen radicals: a question of balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

The role of advanced glycation end-products (AGEs) in the development of vascular diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Differential accumulation of advanced glycation end products in the course of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Renal catabolism of advanced glycation end products: the fate of pentosidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Oxidative stress in arterial hypertension: role of NAD(P)H oxidase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Translocation of Glomerular p47phox and p67phox by Protein Kinase C-β Activation Is Required for Oxidative Stress in Diabetic Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Protein kinase C activation and the development of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Antioxidant defenses and lipid peroxidation in human blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Albumin antioxidant capacity is modified by methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Oxidative stress and antioxidant status in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Selective Rac-1 inhibition protects from diabetes-induced vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302008000700005

10.1590/S0004-27302008000700005

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

PubMed ID

19082297

1 reference

3 June 2018